Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients.

@article{Wijdicks1999OralCD,
  title={Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients.},
  author={Eelco F. M. Wijdicks and L J Dahlke and Russell H. Wiesner},
  journal={Neurology},
  year={1999},
  volume={52 8},
  pages={1708-10}
}
Neoral is a new formulation of cyclosporine that permits reliable absorption in patients with external biliary drainage. The authors reviewed 227 liver transplant patients receiving primary treatment with Neoral. Headache occurred in 24 patients (11%), mild tremors in 12 patients, paresthesia in 5 patients, acute confusional state in 4 patients, and… CONTINUE READING